Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $2.4852W HIGH $15.70
Volume
3.27 M
Value Traded
9.36 M
Short % Float
14.8%
Days to Cover
4.5
+11.76%Week
-15.18%1 Month
-35.52%3 Month
-48.28%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
421.19 M
EPS (TTM)
-1.11
P/E Ratio
-
Ent. Value
389.15 M
Total Shares
147.79 M
Float Shares
145.44 M
Insiders
1.59%
Institutions
9.76%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
PoA blends historical approval base rates, trial design score and FDA review track record.
TLRY Catalyst Timeline
Dated clinical, regulatory and corporate events for Tilray Brands, Inc.
Catalyst Timeline
Dated clinical, regulatory & corporate events for Tilray Brands, Inc.
32Total events
8Upcoming
8Tier-1 (high impact)
2026 to 2028Coverage
Upcoming catalysts 2
Event history 23
●Manufacturing MilestoneCMC / Inspection
Consolidation of Foss cultivation and pre-roll production into Masson and Cayuga facilities
●Restructuring LayoffsCorporate
Consolidated U.S. brewing footprint from 10 facilities to six
▲Partnership / LicenseCorporate
BrewDog signs five-year partnership with Leicester Tigers as official beer partner
▲Partnership / LicenseCorporate
BrewDog named Official Beer Partner of Leicester Tigers in five-year deal
▲Debt Royalty FinancingCorporate
Tilray reduced total outstanding debt by $42 million fiscal year-to-date
▲Runway Guidance UpdateCorporate
Tilray provides FY2027 adjusted EBITDA guidance of $68M-$75M
▲Quarterly UpdateCorporate
Record fiscal year 2026 net revenue of $915 million and adjusted EBITDA of $61.1 million
●Restructuring LayoffsCorporate
Transitioned Terrapin brewing production from Athens to other Tilray facilities
▲Product LaunchBrewDogPost-Market
BrewDog beers available at Welford Road from first home fixture of 2026-27 season
▲Product LaunchPost-Market
BrewDog beers available throughout Mattioli Woods Welford Road stadium from first home match of 2026-2027 season
▲Product LaunchPost-Market
Launch of 1880 Ale, new ale created exclusively for Leicester Tigers fans
Past FDA Catalysts and PDUFA Decisions
How TLRY actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
Clinical Trial Results
Readouts, endpoints and source filings for every TLRY program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| SIMON IRWIN DDirector, Officer (President and CEO) | Option | 803,563 1,734,920 held | $0.00 | 08/26/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in TLRY
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in TLRY for Q2 2026. | ||||
Ownership Trends
TLRY Short Interest
Shares sold short, counted twice a month.
14.8%
Short % of Float
of tradable shares sold short
21.5M
Shares Sold Short
+14.5% vs prior count
4.5 Moderate
Days to Cover
trading days of normal volume to buy every short share back
4.8M
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-13 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How TLRY ranks across every disease it competes in
Competitive Position is a premium feature
See how TLRY ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialTLRY News
-TLRY
Nov 2, 2026Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth
Tilray Brands announced a consolidation of its Canadian cannabis operations, moving cultivation and pre-roll production to more efficient facilities. This strategy aims to generate approximately US$10 million in annualized cost savings by fiscal 2028. The company also raised its fiscal 2027 Adjusted EBITDA guidance to between $70 million and $75 million, reflecting improved operational efficiency.
Read more →-TLRY
Oct 29, 2026Breckenridge Distillery and University of Denver Athletics Release Limited-Edition Whiskey Celebrating Record 11th NCAA Men’s Hockey Championship
Breckenridge Distillery, a Tilray subsidiary, released 230 bottles of limited-edition bourbon to honor the University of Denver's 11th NCAA hockey title. The distillery collaborated with fans to select the barrel for this 101.7 proof release. Tilray reported that $100 from each sale supports Denver men's ice hockey scholarships. The whiskey retails for $179.99 at select Denver liquor stores.
Read more →-TLRY
Oct 29, 2026Tilray Brands Announces Next Phase of Beverage Transformation
Tilray Brands has successfully consolidated its U.S. brewing operations from 10 to 6 facilities, aiming for $20 million in annual cost savings by fiscal 2028. The company reaffirms its fiscal 2027 Adjusted EBITDA guidance of $68 million to $75 million. A partnership with Carlsberg, launching January 1, 2027, is expected to enhance production and sales.
Read more →-TLRY
Oct 22, 2026Blue Point Brewing Co.’s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews
Blue Point Brewing Co. announced the return of its 22nd Annual Cask Ales Festival on November 7, 2026. The event will feature over 100 unique cask ales, local food trucks, and live music. General admission tickets are priced at $40 and include a tasting glass and samples. The festival is open to guests aged 21 and older.
Read more →-TLRY
Oct 21, 2026West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers
BrewDog and West Ham United F.C. launched Boleyn Brew, a fan-created beer, on October 21, 2026. The 4.5% Oat Lager features tropical fruit and citrus notes, designed with input from supporters. It debuts at London Stadium during a match against Southampton, with limited-edition cans available online. This initiative strengthens the bond between the club and its fans.
Read more →-TLRY
Oct 15, 2026SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia
SweetWater Brewing has launched a sweepstakes for fans aged 21 and older to win tickets to a concert at select AEG venues in Georgia. The sweepstakes runs until December 31, 2026, with two winners chosen from two entry periods. Each winner will receive a concert choice and a gift card for travel expenses.
Read more →-TLRY
Oct 13, 2026Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
Tilray Medical received INFARMED approval for its Cantanhede facility to conduct in-house microbiological and chemical testing. This regulatory milestone enhances quality control and accelerates product release in global markets. The approval positions Tilray as a leader in pharmaceutical-grade medical cannabis, improving efficiency and reducing costs.
Read more →-TLRY
Oct 8, 2026Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution
Tilray Brands reported record first-quarter revenue of $257 million, a 23% increase year-over-year, alongside a gross profit of $77.5 million. The company's international business saw a significant boost, particularly in medical cannabis and beverage sectors. Despite a net loss of $40 million, Tilray remains optimistic about its growth trajectory and reaffirmed its adjusted EBITDA guidance for fiscal 2027.
Read more →-TLRY
Oct 7, 2026BrewDog’s Winning Streak Rolls on with Gold at the Scottish Beer Awards
BrewDog won Gold for Hazy Jane Tropical and Krush Test Dummy at the Scottish Beer Awards. The craft brewer also took Bronze for Black Heart. Tilray Brands owns BrewDog. The wins follow a sweep of nine awards at the 2026 World Beer Awards.
Read more →-TLRY
Oct 7, 2026BrewDog Rallies Beer Lovers Across the UK to Choose Craft
BrewDog has launched its Choose Craft campaign across the UK, aiming to celebrate the quality and character of craft beer. Sales of its Punk IPA have surged 2.87 times compared to last year. The campaign includes new partnerships and innovative beer offerings, reinforcing BrewDog's commitment to craft beer excellence.
Read more →-TLRY
Sep 30, 2026▼ -5.1%on this news
10 Barrel Expands Salty Sips RTD Portfolio with New Blackberry Refresher
10 Barrel Brewing has launched the Salty Sips Blackberry Refresher, a low-sugar vodka cocktail. This new addition features real blackberry juice and a hint of sea salt, crafted for a refreshing taste. Following the success of Watermelon Refresher, it aims to cater to consumers seeking flavorful, easy-drinking options. The product is now available in select markets.
Read more →-TLRY
Sep 28, 2026BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team
BrewDog announced new senior leadership appointments to enhance its growth strategy under Tilray Brands. The new team includes experts in marketing, hospitality, and international commercial leadership. These appointments aim to strengthen brand focus and unlock growth opportunities across global markets. BrewDog is committed to building a stronger brand and enhancing customer experiences.
Read more →-TLRY
Sep 25, 2026Tilray Brands to Announce First Quarter Fiscal Year 2027 Financial Results on October 8, 2026
Tilray Brands, Inc. will release its financial results for the first fiscal quarter of 2027 on October 8, 2026. The announcement is scheduled before market opening, followed by a live conference call at 8:30 AM ET. This event will be accessible via webcast on Tilray's Investor Relations website.
Read more →-TLRY
Sep 8, 2026BrewDog Roars into Rugby with Five-Year Leicester Tigers Partnership, Bringing Punk Energy to Welford Road
BrewDog has announced a five-year partnership with Leicester Tigers, becoming the club's Official Beer Partner starting from the 2026-27 season. This collaboration aims to enhance the matchday experience with exclusive beers, including a specially crafted 1880 Ale for fans. BrewDog will also implement new technology and fan activations at the stadium, reinforcing its commitment to community engagement.
Read more →-TLRY
Aug 6, 2026Tilray Brands Expands THC Beverage Innovation with the Launch of Mollo Lite Blackberry Lemon Seltzer Multi-Pack
Tilray Brands has launched the Mollo Lite Blackberry Lemon Seltzer 4-Pack, a low-dose THC beverage aimed at adult consumers. This product expands Tilray's leadership in Canada's cannabis beverage market, offering a refreshing and sessionable option. Each can contains 2.5 mg of THC, catering to the growing demand for lower-dose cannabis beverages.
Read more →-TLRY
Jul 28, 2026Tilray Brands Delivers Record Fiscal 2026 Revenue and Adjusted EBITDA; Demonstrating the Strength of its Diversified Global Platform Across Cannabis, Beverage, Hospitality and Wellness
Tilray Brands reported record fiscal 2026 revenue of $915 million, reflecting a strong growth strategy across its diversified platform in cannabis, beverage, hospitality, and wellness. The company achieved a 34% increase in international medical cannabis revenue and improved its adjusted EBITDA to $61.1 million. Despite a net loss of $105.2 million, Tilray remains optimistic about future growth, projecting over $1 billion in annual revenue for fiscal 2027.
Read more →-TLRY
Jul 23, 2026Tilray Brands Launches ZONNA, Introducing New THC Pouches for Cannabis Consumers
Tilray Brands has launched ZONNA, a new cannabis brand featuring fast-acting THC pouches. Designed for discreet and smoke-free consumption, these pouches utilize innovative Capsoil™ technology. Each pouch contains 10 mg of THC, ensuring a controlled dose. The product is now available through licensed retailers across Canada.
Read more →-TLRY
Jul 17, 2026BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland
BrewDog and Tilray Brands have launched a £1 million bar tab for football fans in England, Scotland, and Ireland, starting July 20, 2026. This initiative aims to enhance the football experience by encouraging fans to gather at participating BrewDog pubs. Fans can redeem two free pints per person through BrewDog's Treats loyalty platform until September 30, 2026.
Read more →-TLRY
Jul 13, 2026Tilray Brands to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on July 28, 2026
Tilray Brands, Inc. will release its financial results for Q4 and fiscal year 2026 on July 28, 2026. The announcement will be followed by a live conference call at 4:30 PM ET, which will be accessible via a webcast. The company continues to position itself as a leader in the cannabis and wellness sectors.
Read more →-TLRY
Jun 29, 2026Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition
Tilray Brands has announced the acquisition of HelloMD Corporation, a digital healthcare platform, to enhance its medical cannabis offerings in Canada. This acquisition aims to improve direct-to-patient capabilities and create a fully integrated framework for medical cannabis. It will also support patient education and engagement, positioning Tilray for growth in the global medical cannabis market.
Read more →About Tilray Brands, Inc.
Headquarters445 PARK AVENUE, NEW YORK, NY, 10022
BIOPHARMAWATCH ELITE PLUS
Trade the next TLRY catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime